80 related articles for article (PubMed ID: 12888883)
1. Circulating t-PA antigen predicts major adverse coronary events in patients with stable coronary artery disease--a 13-year follow-up.
Niessner A; Graf S; Nikfardjam M; Speidl WS; Huber-Beckmann R; Zorn G; Wojta J; Huber K
Thromb Haemost; 2003 Aug; 90(2):344-50. PubMed ID: 12888883
[TBL] [Abstract][Full Text] [Related]
2. Endothelial fibrinolytic capacity predicts future adverse cardiovascular events in patients with coronary heart disease.
Robinson SD; Ludlam CA; Boon NA; Newby DE
Arterioscler Thromb Vasc Biol; 2007 Jul; 27(7):1651-6. PubMed ID: 17463331
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic response to venous occlusion compared to physical stress test in young patients with coronary artery disease.
Nikfardjam M; Graf S; Beckmann R; Hornykewycz S; Koller-Strametz J; Binder BR; Huber K
Thromb Haemost; 1999 Sep; 82 Suppl 1():80-4. PubMed ID: 10695493
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator, von Willebrand factor, and risk of type 2 diabetes in older men.
Wannamethee SG; Sattar N; Rumley A; Whincup PH; Lennon L; Lowe GD
Diabetes Care; 2008 May; 31(5):995-1000. PubMed ID: 18235054
[TBL] [Abstract][Full Text] [Related]
5. Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study.
May M; Lawlor DA; Patel R; Rumley A; Lowe G; Ebrahim S
Eur J Cardiovasc Prev Rehabil; 2007 Oct; 14(5):638-45. PubMed ID: 17925622
[TBL] [Abstract][Full Text] [Related]
6. von Willebrand factor antigen, tissue-type plasminogen activator antigen, and risk of death in human immunodeficiency virus 1-related clinical disease: independent prognostic relevance of tissue-type plasminogen activator.
Schved JF; Gris JC; Arnaud A; Martinez P; Sanchez N; Wautier JL; Sarlat C
J Lab Clin Med; 1992 Sep; 120(3):411-9. PubMed ID: 1517688
[TBL] [Abstract][Full Text] [Related]
7. Predictive value of tissue plasminogen activator mass concentration on long-term mortality in patients with coronary artery disease. A 7-year follow-up.
Jansson JH; Olofsson BO; Nilsson TK
Circulation; 1993 Nov; 88(5 Pt 1):2030-4. PubMed ID: 8222095
[TBL] [Abstract][Full Text] [Related]
8. Pre-existing anticardiolipin antibodies and development of restenosis after coronary balloon angioplasty: predictive value for a complicated course?
Niessner A; Hornykewycz S; Graf S; Nikfardjam M; Speidl WS; Probst P; Zorn G; Maurer G; Wojta J; Huber K
Blood Coagul Fibrinolysis; 2004 Jun; 15(4):311-6. PubMed ID: 15166916
[TBL] [Abstract][Full Text] [Related]
9. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
[TBL] [Abstract][Full Text] [Related]
10. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group.
Thompson SG; Kienast J; Pyke SD; Haverkate F; van de Loo JC
N Engl J Med; 1995 Mar; 332(10):635-41. PubMed ID: 7845427
[TBL] [Abstract][Full Text] [Related]
11. Vascular and fibrinolytic effects of intra-arterial tumour necrosis factor-alpha in patients with coronary heart disease.
Robinson SD; Dawson P; Ludlam CA; Boon NA; Newby DE
Clin Sci (Lond); 2006 Mar; 110(3):353-60. PubMed ID: 16309383
[TBL] [Abstract][Full Text] [Related]
12. Tissue-type plasminogen activator and C-reactive protein in acute coronary heart disease. A nested case-control study.
Gram J; Bladbjerg EM; Møller L; Sjøl A; Jespersen J
J Intern Med; 2000 Feb; 247(2):205-12. PubMed ID: 10692083
[TBL] [Abstract][Full Text] [Related]
13. Long-term prognostic value of IgM antibodies against phosphorylcholine for adverse cardiovascular events in patients with stable coronary heart disease.
Imhof A; Koenig W; Jaensch A; Mons U; Brenner H; Rothenbacher D
Atherosclerosis; 2015 Dec; 243(2):414-20. PubMed ID: 26520895
[TBL] [Abstract][Full Text] [Related]
14. Association between brain-derived neurotrophic factor and von Willebrand factor levels in patients with stable coronary artery disease.
Jin H; Chen Y; Wang B; Zhu Y; Chen L; Han X; Ma G; Liu N
BMC Cardiovasc Disord; 2018 Feb; 18(1):23. PubMed ID: 29409455
[TBL] [Abstract][Full Text] [Related]
15. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
[TBL] [Abstract][Full Text] [Related]
16. Plasma lipoprotein(a) concentration predicts future coronary and cardiovascular events in patients with stable coronary heart disease.
Nestel PJ; Barnes EH; Tonkin AM; Simes J; Fournier M; White HD; Colquhoun DM; Blankenberg S; Sullivan DR
Arterioscler Thromb Vasc Biol; 2013 Dec; 33(12):2902-8. PubMed ID: 24092750
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator antigen and D-dimer as markers for atherothrombotic risk among healthy postmenopausal women.
Pradhan AD; LaCroix AZ; Langer RD; Trevisan M; Lewis CE; Hsia JA; Oberman A; Kotchen JM; Ridker PM
Circulation; 2004 Jul; 110(3):292-300. PubMed ID: 15238458
[TBL] [Abstract][Full Text] [Related]
18. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324
[TBL] [Abstract][Full Text] [Related]
19. Haemostatic biomarkers are associated with long-term recurrent vascular events after ischaemic stroke.
Pedersen A; Redfors P; Lundberg L; Gils A; Declerck PJ; Nilsson S; Jood K; Jern C
Thromb Haemost; 2016 Aug; 116(3):537-43. PubMed ID: 27357914
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
Petersen KR
Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
